77 completed. 77 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 77 | Completed 77 |
| Phase 2 | 3 | Completed 3 |
Follow Contraception: new trials by email Literature Review of Contraception trials Research Report on Contraception
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Trial of Efficacy, Safety and Tolerability of LVDS (Levonorgestrel Vaginal Delivery System) During 13 Cycles LVDS - Contraception | Phase 3 | Completed | Chemo Research | 1039 | 2023-08-09 | 2026-04-21 |
| Efficacy, Safety, and Tolerability of LPRI-CF113 as an Oral Contraceptive in Females Drospirenone - Contraception, Change in Bone Mineral Density | Phase 3 | Completed | Insud Pharma | 1542 | 2022-08-02 | 2025-10-08 |
| Study of the Safety and Efficacy of MR-100A-01 in Approximately 1200 Healthy Women for up to 13 Cycles MR-100A-01 - Contraception | Phase 3 | Completed | Mylan Technologies Inc. | 1320 | 2021-10-26 | 2026-09-14 |
| Study of the Safety and Contraceptive Efficacy of Relugolix Combination Therapy in Women With Uterine Fibroids or Endometriosis Who Are at Risk for Pregnancy Relugolix Combination Therapy - Contraception | Phase 3 | Completed | Sumitomo Pharma Switzerland GmbH | 1164 | 2021-03-18 | 2026-05-13 |
| A Study to Assess Contraceptive Efficacy and Safety of Etonogestrel (ENG) Implant Beyond 3 Years of Use (MK-8415-060) Radiopaque Etonogestrel (ENG) Implant - Contraception | Phase 3 | Completed | Organon and Co | 498 | 2020-11-19 | 2026-02-18 |
| Comparative Efficacy of Lidocaine Spray Versus Vaginal Misoprostol in IUD Insertion lidocaine spray, vaginal misoprostol, placebo - Contraception | Phase 3 | Completed | Cairo University | 147 | 2020-05-01 | 2021-12-10 |
| Comparative Safety and Efficacy of Vaginal Misoprostol Versus Lidocaine-prilocaine Cream in Levonorgestrel IUD Insertion vaginal misoprostol, Lidocaine-Prilocaine Topical cream, placebo - Contraception | Phase 3 | Completed | Cairo University | 210 | 2020-04-30 | 2021-05-07 |
| A Multicenter, Non-Comparative Trial on the Contraceptive Efficacy, Safety, and Tolerability of LPRI-424, 13 Cycles LPRI424 (dienogest/ethinylestradiol) - Contraception | Phase 3 | Completed | Insud Pharma | 1034 | 2019-12-03 | 2023-11-14 |
| Adherence With Continuous-dose Oral Contraceptive: Evaluation of Self-Selection and Use Norgestrel 0.075 mg tablets - Contraception | Phase 3 | Completed | HRA Pharma | 962 | 2019-09-06 | 2022-05-20 |
| Sayana® Press Extension Study Sayana® Press - Contraception | Phase 3 | Completed | FHI 360 | 750 | 2017-09-22 | 2024-08-30 |
| Lidocaine In-situ Gel Prior to Intrauterine Device Insertion in Women With no Previous Vaginal Delivery lidocaine gel, placebo gel - Contraception | Phase 3 | Completed | Assiut University | 216 | 2017-09-01 | 2020-10-06 |
| AMP002 Phase III Contraceptive Study AMPHORA - Contraception | Phase 3 | Completed | Evofem Inc. | 1384 | 2017-07-24 | 2020-09-17 |
| Intervention to End Recurrent Unscheduled Bleeding Trial Ulipristal Acetate, Placebo oral capsule - Contraception, Bleeding | Phase 3 | Completed | Washington University School of Medicine | 65 | 2017-05-01 | 2018-08-31 |
| LCS16 vs. COC User Satisfaction and Tolerability Study Levonorgestrel (Kyleena, BAY86-5028), Ethinyl estradiol and drospirenone (Yarina, BAY86-5131) - Contraception | Phase 3 | Completed | Bayer | 145 | 2017-03-13 | 2023-06-18 |
| Mirena Extension Trial Levonorgestrel IUS (Mirena, BAY86-5028) - Contraception | Phase 3 | Completed | Bayer | 364 | 2016-12-22 | 2022-04-28 |
| E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - United States/Canada Study 15 mg E4/3 mg DRSP - Contraception | Phase 3 | Completed | Estetra | 2148 | 2016-08-30 | 2020-02-10 |
| E4 FREEDOM (Female Response Concerning Efficacy and Safety of Estetrol/Drospirenone as Oral Contraceptive in a Multicentric Study) - EU/Russia Study 15 mg E4/3 mg DRSP - Contraception | Phase 3 | Completed | Estetra | 1577 | 2016-06-01 | 2019-10-04 |
| Vaginal Misoprostol Before Intrauterine Contraceptive Device Insertion Misoprostol, Placebos - Contraception | Phase 3 | Completed | Ain Shams University | 90 | 2015-10-01 | 2018-12-31 |
| Safety and Contraceptive Efficacy of an Intravaginal Ring With LNG (Levonorgestrel) Over One Year in Healthy Women Levonorgestrel (BAY98-7196) - Contraception | Phase 3 | Completed | Bayer | 1471 | 2015-05-15 | 2021-04-08 |
| Safety, Efficacy, Tolerability and Pharmacokinetics of LF111 (Drospirenone 4.0 mg) During 13 Cycles LF111 (drospirenone) - Contraception | Phase 3 | Completed | Laboratories Leon Farma, S.A. | 1552 | 2014-10-09 | 2019-08-06 |
Showing 20 of 77. Sign in to see all of them.
Hemorrhage (2) · Neural Tube Defects (2) · Contraception Behavior (1) · Endometriosis (1) · Leiomyoma (1) · Menorrhagia (1) · Sexual Dysfunction, Physiological (1)
Genital Diseases (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Urogenital Diseases (3) · Congenital Abnormalities (2) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Genital Diseases, Female (2) · Nervous System Diseases (2) · Nervous System Malformations (2) · Behavior (1) · Hemorrhage (1) · Menstruation Disturbances (1) · Neoplasms (1)
Ethinyl Estradiol (13) · drospirenone and ethinyl estradiol combination (9) · drospirenone (8) · Levonorgestrel (7) · Ethinyl Estradiol-Norgestrel Combination (5) · norelgestromin (4) · etonogestrel (3) · Endoglin (2) · Estetrol (2) · Gestodene (2) · Norethindrone Acetate (2) · ST 1435 (2) · dienogest (2) · ethinyl estradiol, levonorgestrel drug combination (2) · ethinyl estradiol-desogestrel combination (2)
Bayer (30) · Organon and Co (9) · Duramed Research (3) · Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (3) · Agile Therapeutics (2) · Cairo University (2) · Estetra (2) · Evofem Inc. (2) · HRA Pharma (2) · Insud Pharma (2) · Warner Chilcott (2) · Ain Shams University (1) · Assiut University (1) · CONRAD (1) · Chemo Research (1)
United States (36) · Germany (9) · Austria (7) · Canada (7) · Finland (6) · France (6) · Spain (6) · Australia (5) · Belgium (4) · Chile (4) · China (4) · Egypt (4) · Netherlands (4) · Sweden (4) · Brazil (3)
Enrico Colli, MD (3) · Alfred Poindexter, MD (1) · Anna F Glasier, MD (1) · Brian T Nguyen, MD, MSc (1) · David Archer, MD (1) · Diana L. Blithe, PH.D. (1) · Elizabeth Garner, MD, MPH (1) · Gilberto De Nucci, Doctor (1) · Herman Ellman (1)
PMID 11849631, PMID 11849634, PMID 21277674, PMID 21721590, PMID 25712537, PMID 26267119, PMID 31231065, PMID 31398307, PMID 37023457, PMID 38295968, PMID 11704172, PMID 19835717, PMID 20004272, PMID 20116841, PMID 20695770, PMID 21074011, PMID 21903192, PMID 21995590, PMID 22066891, PMID 22067790, PMID 22281416, PMID 22454003, PMID 22454004, PMID 22525910, PMID 22540269, PMID 22762147, PMID 22939402, PMID 23493606, PMID 23534865, PMID 23638631, PMID 23921878, PMID 24034466, PMID 24105751, PMID 24240244, PMID 24402597, PMID 24726226, PMID 24993487, PMID 25453582, PMID 25453585, PMID 25582984, PMID 25586864, PMID 25661510, PMID 25751199, PMID 25880636, PMID 26378938, PMID 26410176, PMID 26872720, PMID 26965870, PMID 27016644, PMID 27339759
2008 (3), 2004 (1), 2005 (1)